Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

(1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate

EU orphan designation number: EU/3/12/966
Active ingredient: (1-methyl-2-nitro-1H-imidazole-5-yl)methyl N,N'-bis(2-bromoethyl) diamidophosphate
Indication: Treatment of soft tissue sarcoma
Sponsor: Merck KGaA
Frankfurter Straße 250, D-64293 Darmstadt, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
07/03/2012 Orphan designation EMA/OD/110/11 (2012)1532 of 05/03/2012
12/02/2013 Change of name and/or address of sponsor
09/03/2015 Transfer of orphan designation EMA/OD/110/11/T/01 (2015)1601 of 05/03/2015